What is the appropriate workup and management for chronic vulvar pruritus (chronic vaginal itching)?

Chronic Vulvar Pruritus: Workup and Management

For chronic vulvar itching, begin with wet mount microscopy and vaginal pH testing to diagnose vulvovaginal candidiasis (the most common infectious cause), then examine for dermatologic conditions like lichen sclerosus or eczema, and treat accordingly with topical azoles for candidiasis or high-potency corticosteroids for inflammatory dermatoses.

Diagnostic Approach

Initial Clinical Assessment

The evaluation must focus on specific discriminating features 1, 2:

• Duration and pattern: Chronic (>3 months) vs. acute/recurrent episodes
• Associated symptoms: Discharge (suggests infection), burning, dyspareunia, external dysuria
• Vaginal pH: Normal pH (≤4.5) suggests candidiasis; elevated pH points to bacterial vaginosis or trichomoniasis 3
• Visual inspection: Look for erythema, white discharge, excoriation, lichenification, hypopigmentation, or atypical lesions

Essential Diagnostic Tests

Perform immediately:

• Wet mount preparation with 10% KOH: Visualizes yeasts, pseudohyphae, or mycelia for candidiasis diagnosis 3
• Vaginal pH measurement: Critical for narrowing differential 3
• Fungal culture: Especially important if symptoms are recurrent or refractory, to identify non-albicans species like Candida glabrata 4

Consider when initial workup is negative:

• Skin biopsy: Essential if dermatologic conditions (lichen sclerosus, lichen simplex chronicus, VIN) are suspected 1, 5
• Patch testing: For suspected allergic contact dermatitis 6

Common Pitfalls to Avoid

• Do not treat Candida colonization without symptoms: 10-20% of asymptomatic women harbor Candida species 3
• Do not assume all itching is yeast: Overuse of OTC antifungals delays diagnosis of dermatologic conditions 4
• Do not miss vulvar intraepithelial neoplasia (VIN): Always biopsy refractory or atypical lesions 1

Management by Etiology

Vulvovaginal Candidiasis (Most Common Infectious Cause)

For uncomplicated VVC (sporadic, mild-moderate symptoms, normal host) 4:

Topical azoles (80-90% effective):

• Clotrimazole 1% cream 5g intravaginally for 7-14 days, OR
• Miconazole 2% cream 5g intravaginally for 7 days, OR
• Terconazole 0.4% cream 5g intravaginally for 7 days

Oral option:

• Fluconazole 150mg single oral dose

For complicated/recurrent VVC (≥4 episodes/year, severe symptoms, immunocompromised, non-albicans species) 4:

• Initial therapy: 7-14 days of topical azole OR fluconazole 150mg repeated 3 days later
• Maintenance regimen: Fluconazole 150mg weekly for 6 months after achieving remission

Dermatologic Conditions

Lichen sclerosus 1:

• High-potency topical corticosteroids (clobetasol propionate 0.05% ointment)
• Long-term maintenance therapy required
• Regular monitoring for malignant transformation

Lichen simplex chronicus 5:

• High-potency topical corticosteroids to break itch-scratch cycle
• Behavioral modification and habit reversal training
• Address underlying triggers (irritants, allergens)

Vulvar eczema/contact dermatitis 6, 1:

• Eliminate irritants (soaps, fragrances, tight clothing)
• Topical corticosteroids
• Emollients for barrier repair

When No Clear Cause is Identified

If comprehensive workup is negative and symptoms persist 2, 7:

1. Symptomatic management:

   • Consistent moisturizing care with bland emollients
   • Avoid potential triggers (irritants, heat, friction)
   • Cool compresses for acute relief

2. Consider vulvodynia if pain predominates over itching and workup is negative 8

3. Psychosocial support: Refer to psychology/psychiatry if significant distress, anxiety, or depression is present 9

Critical Management Principles

• Treat identified pathogens: VVC can coexist with STDs; treat all pathogens present 3, 4
• Avoid empiric treatment without diagnosis: This delays appropriate care and worsens outcomes 4
• Follow-up requirement: Any patient with persistent symptoms after treatment or recurrence within 2 months requires re-evaluation 4
• Partner treatment: Not routinely needed for VVC unless recurrent infection or male partner has symptomatic balanitis 4

Age-Specific Considerations

Postmenopausal women 7:

• Consider genitourinary syndrome of menopause (vulvovaginal atrophy)
• Broader differential includes autoimmune conditions
• May require vaginal estrogen therapy in addition to specific treatments

Reproductive age 10:

• Infectious causes (especially VVC) predominate
• Consider hormonal factors and hygiene practices